Biomarker accuracy: exploring the truth
How useful is ICP-MS for determining PK properties of metal-based drugs?
Blood-based biomarker has implications for diagnosis of Parkinson's disease
Co-development project for companion diagnostic announced
Multiplatform approach important for metabolic fingerprinting
New partnership plans to elucidate on the genetic basis of oral cancer
Assay increases detection rates for colorectal cancer
Conference Report: Clinical and Pharmaceutical Solutions through Analysis (CPSA USA 2013): Connecting Patients and Subject Numbers Through Analysis
Bioanalysis Zone: DBS survey results
Blood microsampling using capillaries for drug-exposure determination in early preclinical studies: a beneficial strategy to reduce blood sample volumes
Multiplexed extraction and quantitative analysis of pharmaceuticals from DBS samples using digital microfluidics
Salt-assisted LLE combined with field-amplified sample stacking in CE for improved determination of beta blocker drugs in human urine
Development of an UPLC–MS/MS method for assaying the enzymatic activity of propionyl coenzyme-A carboxylase
Bioanalytical challenges of biosimilars
Detection of volatile malodorous compounds in breath: current analytical techniques and implications in human disease
Quantitative whole-body autoradiography, LC–MS/MS and MALDI for drug-distribution studies in biological samples: the ultimate matrix trilogy
ISR: background, evolution and implementation, with specific consideration for ligand-binding assays
Metabolomics applied in neonatology
Anatomy of noise in quantitative biological Raman spectroscopy